Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • Mitraclip-Mitral valve...

    Mitraclip-Mitral valve placation for the treatment of obstructive hypertrophic cardiomyopathy

    Written by supriya kashyap kashyap Published On 2016-09-16T13:30:30+05:30  |  Updated On 16 Sept 2016 1:30 PM IST
    Mitraclip-Mitral valve placation for the treatment of obstructive hypertrophic cardiomyopathy
    Therapeutic targeting of the mitral valve in individuals with severe heart failure due to obstructive hypertrophic cardiomyopathy (HCM) has attracted interest with the recognition that mitral leaflet elongation and enlargement is common in these patients.


    Sorajja and colleagues hypothesized that percutaneous plication of the mitral valve could reduce left ventricular outflow tract (LVOT) obstruction and systolic anterior motion (SAM) of the valve, thereby reducing associated mitral regurgitation (MR) and leading to amelioration of heart failure symptoms.


    Six patients (mean age; 5 women) with severe, drug-refractory heart failure symptoms due to obstructive HCM (NYHA functional class III) and judged as not optimal candidates for septal myectomy were referred for percutaneous mitral valve leaflet plication with the transcatheter Mitraclip system.


    In 5 patients, the procedure was completed with placement of a single clip in the A2-P2 region of the mitral valve. One patient experienced cardiac tamponade requiring pericardiocentesis, leading to termination of the procedure.


    In the 5 treated patients, percutaneous plication resulted in elimination of SAM and a reduction in the LVOT gradient (91 mm Hg vs. 12 mm Hg; p=0.007), left atrial pressure (29 mm Hg vs 20 mm Hg;), and MR grade (3 vs. 0.8). In the 4 patients who underwent measurement, cardiac output was increased .


    Over a mean follow-up of 15 months, symptom improvement to NYHA functional class I or II occurred in all patients. The 2 patients with mild symptoms had mean mitral valve gradients ≥4 mm Hg immediately after clip deployment, and 5 mm Hg and 8 mm Hg, respectively, at follow-up, consistent with moderate mitral stenosis, said the investigators.


    Follow-up echocardiography showed continued absence of SAM and significant reduction in MR, although high systolic LVOT velocities (i.e., >4 m/s) were evident in 3 of the 5 treated patients.


    The investigators concluded that percutaneous mitral valve plication might be effective as a primary therapy for severely symptomatic, obstructive HCM patients. The intervention led to symptom relief via a reduction of SAM and mitral regurgitation. The significance of persistent elevations of LVOT velocities in some patients requires further study, but if deemed effective in further study, mitral valve plication could represent a viable treatment option for patients who are elderly or with unacceptable risk for surgical myectomy.


    References

    · 1 Sorajja P, Pedersen WA, Bae R, et al (Maron BJ, senior author). First experience with percutaneous mitral valve plication as primary therapy for symptomatic obstructive hypertrophic cardiomyopathy.J Am Coll Cardiol. 2016; 67: 2811-8.

    · 2 Smith, T. Example Title Provided. JAMA; 2015; 15(3): 967-969.
    HCMhypertrophic cardiomyopathyleft ventricular outflow tractLVOTMitral RegurgitationMitral valveMitral valve placationSAMsystolic anterior motion

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok